Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Benjamin

Showing results (271-280 of 462) with videos related to

Pageof 47
Sort By:
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 9, 2020
Association between neonatal intensive care unit medication safety practices, adverse events, and deathLaura E Miller, Chris DeRienzo, P Brian Smith, et al.
Pediatrics|January 7, 2006
Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 monthsDaniel K Benjamin, Barbara J Stoll, Avory A Fanaroff, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 12, 2026
Duration of Antibiotic Therapy for <i>Escherichia coli</i> Bacteremia in Infants With Normal Cerebrospinal Fluid Studies and Without MeningitisAshley Stark, Veronica Quiett, Thomas Roberts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2013
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaHelen W Boucher, George H Talbot, Daniel K Benjamin, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
The Journal of Pediatrics|November 19, 2021
Mortality Risk Factors among Infants Receiving Dialysis in the Neonatal Intensive Care UnitKeia R Sanderson, Bradley Warady, William Carey, et al.
The Pediatric Infectious Disease Journal|September 17, 2015
Cefepime and Ceftazidime Safety in Hospitalized InfantsChristopher J Arnold, Jessica Ericson, Nathan Cho, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infectionsDaniel K Benjamin, Timothy Driscoll, Nita L Seibel, et al.
The Pediatric Infectious Disease Journal|March 12, 2015
No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infantsJessica E Ericson, Joshua Thaden, Heather R Cross, et al.
Pageof 47

Showing results (271-280 of 462) with videos related to

Sort By:
Pageof 47
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 9, 2020
Association between neonatal intensive care unit medication safety practices, adverse events, and deathLaura E Miller, Chris DeRienzo, P Brian Smith, et al.
Pediatrics|January 7, 2006
Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 monthsDaniel K Benjamin, Barbara J Stoll, Avory A Fanaroff, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 12, 2026
Duration of Antibiotic Therapy for <i>Escherichia coli</i> Bacteremia in Infants With Normal Cerebrospinal Fluid Studies and Without MeningitisAshley Stark, Veronica Quiett, Thomas Roberts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2013
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaHelen W Boucher, George H Talbot, Daniel K Benjamin, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
The Journal of Pediatrics|November 19, 2021
Mortality Risk Factors among Infants Receiving Dialysis in the Neonatal Intensive Care UnitKeia R Sanderson, Bradley Warady, William Carey, et al.
The Pediatric Infectious Disease Journal|September 17, 2015
Cefepime and Ceftazidime Safety in Hospitalized InfantsChristopher J Arnold, Jessica Ericson, Nathan Cho, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infectionsDaniel K Benjamin, Timothy Driscoll, Nita L Seibel, et al.
The Pediatric Infectious Disease Journal|March 12, 2015
No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infantsJessica E Ericson, Joshua Thaden, Heather R Cross, et al.
Pageof 47